FGF21 suppresses hepatic glucose production through the activation of atypical protein kinase Ci/λ

European Journal of Pharmacology

Volumn 702, Issue 1-3, 2013, Pages 302-308

  Kong, Ling Jie ^a   Feng, Wen ^a   Wright, Michael ^a   Chen, Yuli ^a   Dallas Yang, Qing ^a   Zhou, Yun Ping ^a   Berger, Joel P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Fibroblast growth factor 21; Gluconeogenesis; Protein kinase C

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; ISOENZYME; LIVER ENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C IOTA; PROTEIN KINASE C LAMBDA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE, TUMOR; DIABETES MELLITUS; FIBROBLAST GROWTH FACTORS; GLUCOSE; HEK293 CELLS; HUMANS; ISOENZYMES; LIVER; MALE; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; RATS;

EID: 84874933239     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.065     Document Type: Article

References (32)

1. D. Argaud, Q. Zhang, W. Pan, S. Maitra, S.J. Pilkis, and A.J. Lange Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence Diabetes 45 1996 1563 1571
2. G. Bandyopadhyay, Y. Kanoh, M.P. Sajan, M.L. Standaert, and R.V. Farese Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes Endocrinology 141 2000 4120 4127
3. E.D. Berglund, C.Y. Li, H.A. Bina, S.E. Lynes, M.D. Michael, A.B. Shanafelt, A. Kharitonenkov, and D.H. Wasserman Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity Endocrinology 150 2009 4084 4093
4. M.D. Chau, J. Gao, Q. Yang, Z. Wu, and J. Gromada Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway Proc. Natl. Acad. Sci. USA 107 2010 12553 12558
5. T. Coskun, H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, Y. Chen, D.E. Moller, and A. Kharitonenkov Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
6. D. Cuevas-Ramos, P. Almeda-Valdes, C.A. Aguilar-Salinas, G. Cuevas-Ramos, A.A. Cuevas-Sosa, and F.J. Gomez-Perez The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism Curr. Diabetes Rev. 5 2009 216 220
7. D. DeFeo-Jones, S.F. Barnett, S. Fu, P.J. Hancock, K.M. Haskell, K.R. Leander, E. McAvoy, R.G. Robinson, M.E. Duggan, C.W. Lindsley, Z. Zhao, H.E. Huber, and R.E. Jones Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members Mol. Cancer Ther. 4 2005 271 279
8. R.V. Farese, and M.P. Sajan Metabolic functions of atypical protein kinase C: good and bad as defined by nutritional status Am. J. Physiol. Endocrinol. Metab. 298 2010 E385 394
9. R.V. Farese, M.P. Sajan, H. Yang, P. Li, S. Mastorides, W.R. Gower Jr., S. Nimal, C.S. Choi, S. Kim, G.I. Shulman, C.R. Kahn, U. Braun, and M. Leitges Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes J. Clin. Invest. 117 2007 2289 2301
10. N. Hashimoto, Y. Kido, T. Uchida, T. Matsuda, K. Suzuki, H. Inoue, M. Matsumoto, W. Ogawa, S. Maeda, H. Fujihara, Y. Ueta, Y. Uchiyama, K. Akimoto, S. Ohno, T. Noda, and M. Kasuga PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells J. Clin. Invest. 115 2005 138 145
11. L. He, A. Sabet, S. Djedjos, R. Miller, X. Sun, M.A. Hussain, S. Radovick, and F.E. Wondisford Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein Cell 137 2009 635 646
12. S. Ito, S. Kinoshita, N. Shiraishi, S. Nakagawa, S. Sekine, T. Fujimori, and Y.I. Nabeshima Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein Mech. Dev. 98 2000 115 119
13. A. Kharitonenkov, J.D. Dunbar, H.A. Bina, S. Bright, J.S. Moyers, C. Zhang, L. Ding, R. Micanovic, S.F. Mehrbod, M.D. Knierman, J.E. Hale, T. Coskun, and A.B. Shanafelt FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J. Cell Physiol. 215 2008 1 7
14. A. Kharitonenkov, and P. Larsen FGF21 reloaded: challenges of a rapidly growing field Trends Endocrinol. Metab. 22 2011 6
15. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, R.A. Owens, J. Gromada, J.T. Brozinick, E.D. Hawkins, V.J. Wroblewski, D.S. Li, F. Mehrbod, S.R. Jaskunas, and A.B. Shanafelt FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
16. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
17. S.A. Kliewer, and D.J. Mangelsdorf Fibroblast growth factor 21: from pharmacology to physiology Am. J. Clin. Nutr. 91 2010 254S 257S
18. K. Kotani, W. Ogawa, M. Matsumoto, T. Kitamura, H. Sakaue, Y. Hino, K. Miyake, W. Sano, K. Akimoto, S. Ohno, and M. Kasuga Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes Mol. Cell. Biol. 18 1998 6971 6982
19. H. Kurosu, M. Choi, Y. Ogawa, A.S. Dickson, R. Goetz, A.V. Eliseenkova, M. Mohammadi, K.P. Rosenblatt, S.A. Kliewer, and M. Kuro-o Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J. Biol. Chem. 282 2007 26687 26695
20. M. Matsumoto, W. Ogawa, K. Akimoto, H. Inoue, K. Miyake, K. Furukawa, Y. Hayashi, H. Iguchi, Y. Matsuki, R. Hiramatsu, H. Shimano, N. Yamada, S. Ohno, M. Kasuga, and T. Noda PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity J. Clin. Invest. 112 2003 935 944
21. J.S. Moyers, T.L. Shiyanova, F. Mehrbod, J.D. Dunbar, T.W. Noblitt, K.A. Otto, A. Reifel-Miller, and A. Kharitonenkov Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling J. Cell. Physiol. 210 2007 1 6
22. R.M. O'Brien, R.S. Streeper, J.E. Ayala, B.T. Stadelmaier, and L.A. Hornbuckle Insulin-regulated gene expression Biochem. Soc. Trans. 29 2001 552 558
23. M.J. Potthoff, T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, M. Mohammadi, B.N. Finck, D.J. Mangelsdorf, S.A. Kliewer, and S.C. Burgess FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc. Natl. Acad. Sci. USA 106 2009 10853 10858
24. M.P. Sajan, J. Rivas, P. Li, M.L. Standaert, and R.V. Farese Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport J. Biol. Chem. 281 2006 17466 17473
25. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806
26. K. Sasaki, T.P. Cripe, S.R. Koch, T.L. Andreone, D.D. Petersen, E.G. Beale, and D.K. Granner Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin J. Biol. Chem. 259 1984 15242 15251
27. M.L. Standaert, L. Galloway, P. Karnam, G. Bandyopadhyay, J. Moscat, and R.V. Farese Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport J. Biol. Chem. 272 1997 30075 30082
28. W. Wei, P.A. Dutchak, X. Wang, X. Ding, X. Wang, A.L. Bookout, R. Goetz, M. Mohammadi, R.D. Gerard, P.C. Dechow, D.J. Mangelsdorf, S.A. Kliewer, and Y. Wan Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma Proc. Natl. Acad. Sci. USA 109 2012 3143 3148
29. W. Wente, A.M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, G.E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2006 2470 2478
30. J. Xu, D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y.S. Li, R.A. Lindberg, J.L. Chen, D.Y. Jung, Z. Zhang, H.J. Ko, J.K. Kim, and M.M. Veniant Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
31. J. Xu, S. Stanislaus, N. Chinookoswong, Y.Y. Lau, T. Hager, J. Patel, H. Ge, J. Weiszmann, S.C. Lu, M. Graham, J. Busby, R. Hecht, Y.S. Li, Y. Li, R.A. Lindberg, and M.M. Veniant Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models - association with liver and adipose tissue effects Am. J. Physiol. Endocrinol. Metab. 297 2009 1105 1114
32. N. Yabaluri, and M.D. Bashyam Hormonal regulation of gluconeogenic gene transcription in the liver J. Biosci. 35 2010 473 484